Table 4.
Module | Term | Representative genes | p-value | FDR |
---|---|---|---|---|
Module103 | GO:0008283 ~ cell proliferation | CREBBP | 0.000353 | 0.00498 |
GO:0006357 ~ regulation of transcription from RNA polymerase II promoter | CREBBP, EP300 | 0.003488 | 0.04824 | |
Module106 | GO:0019221 ~ cytokine-mediated signaling pathway | IRAK4 | 0.001318 | 0.0192 |
hsa04630:Jak-STAT signaling pathway | IFNAR1, STAT2, IRF9 | 0.002251 | 0.0177 | |
Module130 | GO:0006915 ~ apoptosis | HSPE1 | 0.001585 | 0.01762 |
Module159 | GO:0007249 ~ I-kappaB kinase/NF-kappaB cascade | IRF3, TRAF2, TICAM1, BCL3 | 3.58E-08 | 5.43E-07 |
GO:0043068 ~ positive regulation of programmed cell death | TRAF2, TICAM1, BCL3 | 1.46E-07 | 2.21E-06 | |
GO:0002263 ~ cell activation during immune response | TICAM1, BCL3 | 2.23E-05 | 0.00034 | |
GO:0002366 ~ leukocyte activation during immune response | TICAM1, BCL3 | 2.23E-05 | 0.00034 | |
hsa04622:RIG-I-like receptor signaling pathway | IRF3, TRAF2, MAVS | 2.27E-05 | 0.00021 | |
GO:0001819 ~ positive regulation of cytokine production | TRAF2, MAVS, TICAM1, BCL3 | 0.000347 | 0.00526 | |
GO:0051251 ~ positive regulation of lymphocyte activation | TRAF2, TICAM1 | 0.000433 | 0.00655 | |
GO:0045321 ~ leukocyte activation | TICAM1, BCL3 | 0.00047 | 0.00711 | |
GO:0006955 ~ immune response | MAVS, TICAM1, BCL3 | 0.000483 | 0.00731 | |
GO:0009615 ~ response to virus | IRF3, MAVS, TICAM1, BCL3 | 0.000609 | 0.0092 | |
REACT_6900:Signaling in Immune system | IRF3, TICAM1 | 0.001402 | 0.00804 | |
Module171 | hsa04310:Wnt signaling pathway | JUN, MAPK10, DVL2 | 0.000233 | 0.00246 |
hsa04010:MAPK signaling pathway | JUN, MAPK10, MAPK1 | 0.001514 | 0.01594 | |
GO:0034097 ~ response to cytokine stimulus | JUN | 0.00196 | 0.03023 | |
GO:0002237 ~ response to molecule of bacterial origin | JUN, MAPK1 | 0.002673 | 0.04102 | |
Module173 | GO:0006954 ~ inflammatory response | CEBPB, CCL5, F8, BDKRB1, ITGB2, HIF1A, TF, F3, C1RL, IL8 | 3.00E-05 | 0.00048 |
GO:0009611 ~ response to wounding | CEBPB, CCL5, F8, BDKRB1, IGFBP1, ITGB2, NRG1, HIF1A, TF, F3, C1RL, IL8 | 5.28E-05 | 0.00085 | |
GO:0051240 ~ positive regulation of multicellular organismal process | CCL5, PTGS2, NRG1, HIF1A, MYLK2, TF, F3, IL27RA | 0.000197 | 0.00316 | |
GO:0006952 ~ defense response | CEBPB, CCL5, F8, BDKRB1, ITGB2, HIF1A, TF, F3, IL27RA, C1RL, IL8 | 0.000835 | 0.01331 | |
GO:0032101 ~ regulation of response to external stimulus | CCL5, VEGFA, PTGS2, NT5E, F3, IL8 | 0.001131 | 0.01799 | |
REACT_604:Hemostasis | STX4, SLC7A7, F8, VEGFA, ITGB2, ALB, TF, F3 | 0.001131 | 0.00976 | |
GO:0002526 ~ acute inflammatory response | CEBPB, F8, TF, F3, C1RL | 0.0014 | 0.02222 | |
GO:0043069 ~ negative regulation of programmed cell death | CEBPB, VEGFA, NRG1, ALB, KRT18, PPT1, PCSK6, F3 | 0.001937 | 0.03062 | |
Module174 | GO:0051726 ~ regulation of cell cycle | SMAD3, CDK4 | 1.10E-05 | 0.00016 |
GO:0031328 ~ positive regulation of cellular biosynthetic process | SMAD3, CDK4 | 0.000612 | 0.00894 | |
GO:0006350 ~ transcription | SMAD3, ASH2L | 0.000854 | 0.01245 | |
Module175 | GO:0000122 ~ negative regulation of transcription from RNA polymerase II promoter | CTNNB1, | 0.002252 | 0.02972 |
Module178 | GO:0051252 ~ regulation of RNA metabolic process | STAT1, UBE2I, HDAC3, PIAS2, DAXX, SP100 | 5.05E-05 | 0.00076 |
REACT_11061:Signalling by NGF | HDAC3, AKT1 | 0.000413 | 0.00293 | |
GO:0007049 ~ cell cycle | DAXX, UBE2I, HDAC3, AKT1 | 0.0005 | 0.00753 | |
hsa04630:Jak-STAT signaling pathway | STAT1, AKT1, PIAS2 | 0.004991 | 0.04684 | |
Module179 | GO:0006974 ~ response to DNA damage stimulus | RAD54L, FANCI, XAB2, BCCIP, BRCA1, XRCC1, EEPD1, UPF1, RAD51, TOP2A, FANCD2, RAD54B | 3.39E-08 | 4.91E-07 |
REACT_216:DNA Repair | FANCI, XAB2, BRCA1, XRCC1, POLR2K, RAD51, POLR2A, FANCD2 | 1.64E-07 | 1.25E-06 | |
GO:0033554 ~ cellular response to stress | FANCI, RAD54L, XAB2, EEPD1, BRCA1, XRCC1, TOP2A, RAD54B, DHX9, BCCIP, UPF1, RAD51, FANCD2 | 2.71E-07 | 3.92E-06 | |
GO:0007049 ~ cell cycle | FANCI, RAD54L, KIF15, BRCA1, CHTF18, RCC1, RAD54B, CIT, BCCIP, UPF1, TUBB, RAD51, FANCD2 | 7.43E-06 | 0.00011 | |
Module180 | GO:0010604 ~ positive regulation of macromolecule metabolic process | NUP62 | 7.41E-05 | 0.0011 |
Module182 | GO:0006303 ~ double-strand break repair via nonhomologous end joining | PRKDC | 1.88E-06 | 2.83E-05 |
GO:0045935 ~ positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | ILF2, RELA, NFKB1, PRKDC | 0.000934 | 0.01395 | |
GO:0002562 ~ somatic diversification of immune receptors via germline recombination within a single locus | PRKDC | 0.001732 | 0.02573 | |
Module184 | GO:0022402 ~ cell cycle process | MLH1, MAP2K6 | 0.001302 | 0.01777 |
Module185 | GO:0007243 ~ protein kinase cascade | SRC, IKBKB, NFKBIA | 0.001885 | 0.02759 |
Module186 | REACT_1538:Cell Cycle Checkpoints | MCM4, MCM3, MCM5, MCM7, MCM2 | 9.90E-23 | 7.84E-22 |
GO:0006260 ~ DNA replication | MCM4, MCM3, MCM5, MCM7, MCM2 | 1.13E-21 | 1.51E-20 | |
Module189 | GO:0032268 ~ regulation of cellular protein metabolic process | CBS | 0.00036 | 0.00532 |
Module190 | GO:0008380 ~ RNA splicing | SFPQ | 2.23E-06 | 3.19E-05 |
Module200 | REACT_6185:HIV Infection | NUP188, NUP205 | 0.000592 | 0.00484 |
Module206 | hsa04350:TGF-beta signaling pathway | SMURF2, SMAD6 | 0.001698 | 0.00872 |
Module241 | GO:0006913 ~ nucleocytoplasmic transport | NXT1, RAN | 0.001111 | 0.01645 |
Module244 | REACT_12472:Regulatory RNA pathways | POLR2H, POLR2I, POLR2B, POLR2D, POLR2L | 5.52E-10 | 3.65E-09 |
REACT_6143:Pausing and recovery of Tat-mediated HIV-1 elongation | POLR2H, POLR2I, POLR2B, POLR2D, POLR2L | 4.94E-09 | 3.27E-08 | |
REACT_6167:Influenza Infection | POLR2H, POLR2I, POLR2B, POLR2D, POLR2L | 4.39E-06 | 2.91E-05 | |
Module253 | GO:0000398 ~ nuclear mRNA splicing, via spliceosome | HNRNPM | 0.003042 | 0.04485 |
Module267 | hsa04920:Adipocytokine signaling pathway | RXRB | 8.48E-06 | 7.22E-05 |
Module280 | GO:0006984 ~ ER-nuclear signaling pathway | PAK1, EIF2AK3 | 0.001649 | 0.02486 |
Module303 | hsa04144:Endocytosis | VPS28 | 0.000182 | 0.00041 |
'Module’ refers to the module indices we gave. 'Term’ refers to the enriched GO terms (e.g. GO:0008283), KEGG pathways (e.g. hsa04630), and REACTOME pathways (e.g. REACT_6900). Certain genes in the modules are listed as 'Representative genes’. 'p-value’ and 'FDR’ shows the statistical significance of the results.